JNJ

Product Revenue Segments

Latest: 2025 (2025-12-28) · Total: $94.19B
SegmentRevenueShare
Innovative Medicine
$60.40B64.1%
MedTech
$33.79B35.9%
Other
$00.0%

Geographic Revenue Segments

Latest: 2025 (2025-12-28) · Total: $94.19B
SegmentRevenueShare
UNITED STATES
$53.75B57.1%
Europe
$21.54B22.9%
Asia-Pacific, Africa
$14.03B14.9%
Western Hemisphere, excluding U.S.
$4.88B5.2%
Source: SEC filings via FMP · Last updated May 25, 2026
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.